238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.56%
Revenue growth under 50% of BIDU's 12.80%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-0.13%
Negative gross profit growth while BIDU is at 13.53%. Joel Greenblatt would examine cost competitiveness or demand decline.
-12.54%
Negative EBIT growth while BIDU is at 10.16%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-12.54%
Negative operating income growth while BIDU is at 10.16%. Joel Greenblatt would press for urgent turnaround measures.
-18.26%
Negative net income growth while BIDU stands at 9.29%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-16.00%
Negative EPS growth while BIDU is at 9.52%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-20.00%
Negative diluted EPS growth while BIDU is at 9.52%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.29%
Share count expansion well above BIDU's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.27%
Diluted share count expanding well above BIDU's 0.24%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
6.52%
OCF growth of 6.52% while BIDU is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
19.99%
FCF growth of 19.99% while BIDU is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
1554.24%
10Y revenue/share CAGR under 50% of BIDU's 14386.23%. Michael Burry would suspect a lasting competitive disadvantage.
159.83%
5Y revenue/share CAGR under 50% of BIDU's 944.33%. Michael Burry would suspect a significant competitive gap or product weakness.
62.26%
3Y revenue/share CAGR under 50% of BIDU's 222.11%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
1929.07%
OCF/share CAGR of 1929.07% while BIDU is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
105.56%
OCF/share CAGR of 105.56% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
44.85%
3Y OCF/share CAGR of 44.85% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
4151.22%
Below 50% of BIDU's 40482.37%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
56.23%
Below 50% of BIDU's 676.80%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-4.20%
Negative 3Y CAGR while BIDU is 104.93%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
2979.42%
Equity/share CAGR of 2979.42% while BIDU is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
173.94%
Below 50% of BIDU's 1012.85%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
72.03%
Equity/share CAGR of 72.03% while BIDU is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.41%
AR growth well above BIDU's 22.47%. Michael Burry fears inflated revenue or higher default risk in the near future.
-4.78%
Inventory is declining while BIDU stands at 25.22%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.43%
Asset growth at 50-75% of BIDU's 6.79%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
2.90%
Under 50% of BIDU's 8.29%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.04%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
18.63%
R&D growth drastically higher vs. BIDU's 5.43%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
3.11%
SG&A declining or stable vs. BIDU's 25.65%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.